ArticleFrontiers in cardiovascular medicine2022

Twenty-Four Hour Blood Pressure Response to Empagliflozin and Its Determinants in Normotensive Non-diabetic Subjects.

Anne Zanchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.